Lana T Al-Omar1, Sarah L Anderson2, Amber D Cizmic3, Tara B Vlasimsky4. 1. Inpatient Clinical Staff Pharmacist, Denver Health Medical Center, CO. 2. Ambulatory Care Clinical Pharmacy Specialist, Denver Health Medical Center, and Associate Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora. 3. Ambulatory Care Clinical Pharmacy Specialist, Denver Health Medical Center. 4. Assistant Director of Ambulatory Clinical Pharmacy Services, Denver Health Medical Center.
Abstract
BACKGROUND: Little data exist regarding how pharmacist-led collaborative drug therapy management protocols are implemented in health systems. Barriers to collaborative drug therapy management protocol implementation exist, but they can be overcome by effective protocol education and communication, allowing pharmacists to manage more patients with chronic disease states, thereby enhancing quality health outcomes for patients and reducing health resource utilization. OBJECTIVE: To determine the preferred method of provider education regarding the implementation of a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, and to assess pharmacist and provider satisfaction with the protocol implementation. METHODS: This single-center, prospective cohort study included pharmacists practicing within a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, as well as providers practicing at 4 primary care clinics within a health system. All providers received an e-mail regarding education about the protocol. In addition, providers at 2 of the clinics received education about the protocol at a provider meeting, and providers at the other 2 clinics received a personalized provider report card. The personalized provider report card identified patients within the provider's panel who met criteria for referral to a pharmacist under the new protocol. The referred patients were tracked for 2 months, and provider and pharmacist satisfaction with the protocol were assessed. RESULTS: A total of 54 patients were referred for pharmacist management per the protocol. The majority (89%) of patients were referred by providers who received a personalized provider report card. Nearly all (96%) of the providers were satisfied with the protocol-driven services, and most (67%) pharmacists were satisfied with their role in managing patients with type 2 diabetes under the collaborative drug therapy management protocol. CONCLUSION: The majority of patients with type 2 diabetes who were referred for pharmacist management per the protocol were referred by providers who received personalized provider report cards. Provider and pharmacist satisfaction with the new pharmacist-led protocol was high.
BACKGROUND: Little data exist regarding how pharmacist-led collaborative drug therapy management protocols are implemented in health systems. Barriers to collaborative drug therapy management protocol implementation exist, but they can be overcome by effective protocol education and communication, allowing pharmacists to manage more patients with chronic disease states, thereby enhancing quality health outcomes for patients and reducing health resource utilization. OBJECTIVE: To determine the preferred method of provider education regarding the implementation of a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, and to assess pharmacist and provider satisfaction with the protocol implementation. METHODS: This single-center, prospective cohort study included pharmacists practicing within a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, as well as providers practicing at 4 primary care clinics within a health system. All providers received an e-mail regarding education about the protocol. In addition, providers at 2 of the clinics received education about the protocol at a provider meeting, and providers at the other 2 clinics received a personalized provider report card. The personalized provider report card identified patients within the provider's panel who met criteria for referral to a pharmacist under the new protocol. The referred patients were tracked for 2 months, and provider and pharmacist satisfaction with the protocol were assessed. RESULTS: A total of 54 patients were referred for pharmacist management per the protocol. The majority (89%) of patients were referred by providers who received a personalized provider report card. Nearly all (96%) of the providers were satisfied with the protocol-driven services, and most (67%) pharmacists were satisfied with their role in managing patients with type 2 diabetes under the collaborative drug therapy management protocol. CONCLUSION: The majority of patients with type 2 diabetes who were referred for pharmacist management per the protocol were referred by providers who received personalized provider report cards. Provider and pharmacist satisfaction with the new pharmacist-led protocol was high.
Entities:
Keywords:
collaborative drug therapy management; disease management protocol; pharmacist-led management; provider report card; type 2 diabetes
Authors: Kelly Epplen; Michelle Dusing-Wiest; Joanna Freedlund; Nicole Harger; Susan Kathman; Marianne F Ivey Journal: Am J Health Syst Pharm Date: 2007-05-01 Impact factor: 2.637
Authors: Ravi Iyer; Pauline Coderre; Theresa McKelvey; Jason Cooper; Jan Berger; Elizabeth Moore; Mike Kushner Journal: Am J Health Syst Pharm Date: 2010-02-15 Impact factor: 2.637
Authors: Jaime P Anaya; Jose O Rivera; Ken Lawson; Jose Garcia; Jose Luna; Melchor Ortiz Journal: Am J Health Syst Pharm Date: 2008-10-01 Impact factor: 2.637
Authors: Charmaine D Rochester; Nicholas Leon; Robert Dombrowski; Stuart T Haines Journal: Am J Health Syst Pharm Date: 2010-01-01 Impact factor: 2.637
Authors: Alison K Wright; Milton Fabian Suarez-Ortegon; Darren M Ashcroft; Sarah H Wild; Martin K Rutter; Stephanie H Read; Evangelos Kontopantelis; Iain Buchan; Richard Emsley; Naveed Sattar Journal: Circulation Date: 2020-11-16 Impact factor: 29.690